Antibody Drug Conjugates Market Insights: Industry Size, Key Trends, Growth Prospects, Emerging Demands, and Forecast Up to 2028
In July 2023, BeiGene and DualityBio entered into a partnership to advance differentiated antibody drug conjugate (ADC) therapy for solid tumors.
View full press release